Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Knoop

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Transplantation|August 15, 1996
Human heart endothelial-cell-restricted allorecognitionN H Jutte, C J Knoop, P Heijse, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 1, 1997
Cytotoxicity of graft-derived lymphocytes: specific for donor heart endothelial cells?N H Jutte, C J Knoop, P Heijse, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2001
Quantitative flow cytometry shows activation of the TNF-alpha system but not of the IL-2 system at the single cell level in renal replacement therapyI C van Riemsdijk-Van Overbeeke, C C Baan, C J Knoop, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 12, 2000
Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipientsF B Oei, M J Welters, C J Knoop, et al.
Transplantation|March 8, 2000
Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejectionC C Baan, T van Gelder, A H Balk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Evidence that cyclosporin A prevents clinical cardiac allograft rejection by blocking both direct and indirect antigen presentation pathwaysN M van Besouw, L M Vaessen, C J Knoop, et al.
Transplantation|July 29, 1998
C1.7 monoclonal antibody designates high-avidity CD4+ cytotoxic T lymphocytes involved in clinical heart rejectionN E van Emmerik, C J Knoop, L M Vaessen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Quantitative flow cytometry to measure the TNF-alpha and IL-2 system after heart transplantationI C van Riemsdijk, C C Baan, C J Knoop, et al.
Transplant Immunology|December 16, 1998
Kinetics of circulating cytotoxic T lymphocyte precursors that have a high avidity for donor antigens: correlation with the rejection status of the human cardiac allograftN E van Emmerik, L M Vaessen, C J Knoop, et al.
Kidney International|March 7, 2001
T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxisI C van Riemsdijk, C C Baan, E H Loonen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Transplantation|August 15, 1996
Human heart endothelial-cell-restricted allorecognitionN H Jutte, C J Knoop, P Heijse, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 1, 1997
Cytotoxicity of graft-derived lymphocytes: specific for donor heart endothelial cells?N H Jutte, C J Knoop, P Heijse, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2001
Quantitative flow cytometry shows activation of the TNF-alpha system but not of the IL-2 system at the single cell level in renal replacement therapyI C van Riemsdijk-Van Overbeeke, C C Baan, C J Knoop, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 12, 2000
Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipientsF B Oei, M J Welters, C J Knoop, et al.
Transplantation|March 8, 2000
Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejectionC C Baan, T van Gelder, A H Balk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Evidence that cyclosporin A prevents clinical cardiac allograft rejection by blocking both direct and indirect antigen presentation pathwaysN M van Besouw, L M Vaessen, C J Knoop, et al.
Transplantation|July 29, 1998
C1.7 monoclonal antibody designates high-avidity CD4+ cytotoxic T lymphocytes involved in clinical heart rejectionN E van Emmerik, C J Knoop, L M Vaessen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Quantitative flow cytometry to measure the TNF-alpha and IL-2 system after heart transplantationI C van Riemsdijk, C C Baan, C J Knoop, et al.
Transplant Immunology|December 16, 1998
Kinetics of circulating cytotoxic T lymphocyte precursors that have a high avidity for donor antigens: correlation with the rejection status of the human cardiac allograftN E van Emmerik, L M Vaessen, C J Knoop, et al.
Kidney International|March 7, 2001
T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxisI C van Riemsdijk, C C Baan, E H Loonen, et al.
Pageof 2